Beinaglutide

DB15072InvestigationalProtein Based Therapies

Beinaglutide is under investigation in clinical trial NCT03829891 (Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus).

Mechanism: Pharmacologically active on Glucagon-like peptide 1 receptor
Curator reviewed

Resolves to

Compound

UNII38I1O6L31DCAS123475-27-4

Clinical / RWD

ATCA10BJ07

Targets

P43220GLP1R

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 12 drug categories

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Beinaglutide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account